Observational study finds nocturnal hormone bursts may affect aldosterone levels in hypertension — Evidence Review
Published in Science Translational Medicine, by researchers from University of Bristol, University of Manchester, University of Bergen, partner institutions in Stockholm and Athens
Researched by
— the AI search engine for science
Table of Contents
A new study finds that a hidden adrenal hormone disorder may underlie millions of high blood pressure cases, and continuous hormone monitoring with a wearable device can detect this condition where standard tests often fail. Related research generally supports the role of fluctuating hormones (especially aldosterone) in hypertension and highlights the benefit of continuous or ambulatory monitoring for improved diagnosis and management, as discussed by the University of Bristol.
- The discovery of nocturnal hormone surges in primary aldosteronism builds on prior evidence that aldosterone excess contributes to hypertension, particularly through its effects on sodium retention and circadian blood pressure variability 4 8 10.
- Studies show that both continuous blood pressure and hormone monitoring provide more accurate assessments than single-time-point measurements, supporting the new study's approach and underscoring the limitations of conventional diagnostics 10 11 12 14.
- Related reviews and clinical studies emphasize the importance of identifying secondary causes of hypertension, such as adrenal and other endocrine disorders, and suggest that dynamic, time-resolved measurement strategies can improve detection and treatment outcomes 2 3 4 10 14.
Study Overview and Key Findings
Hypertension, or high blood pressure, is a major risk factor for cardiovascular disease, but its underlying causes often remain undiagnosed—particularly in cases involving secondary conditions like primary aldosteronism. This new study highlights a significant gap in current diagnostic practices by demonstrating that brief, previously undetected surges in hormone secretion, especially at night, may drive disease in many patients. By employing a home-based wearable device to capture continuous hormone data, the researchers provide evidence that existing single-point blood tests may miss critical diagnostic information, potentially delaying or preventing appropriate treatment.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | University of Bristol, University of Manchester, University of Bergen, partner institutions in Stockholm and Athens |
| Journal Name | Science Translational Medicine |
| Authors | Marianne A. Grytaas, Thomas Upton, Isabella Marinelli, Paal Methlie, Marianne Øksnes, Dimitra A. Vassiliadi, Sophie Bensing, Georgina Russell, Kristian Løvås, Dimitris Margaritopoulos, Ileana R. Botusan, Katerina Simunkova, Maria Balomenaki, Katarina Berinder, Belinda Lombard, Thea Sjøgren, Ida Løvik, Bergithe E. Oftedal, Anette Heie, Grethe Å. Ueland, Olle Kämpe, Stylianos Tsagarakis, Stafford L. Lightman, Eder Zavala, Eystein S. Husebye |
| Population | Patients with primary aldosteronism |
| Sample Size | 60 patients |
| Methods | Observational Study |
| Outcome | Hormone levels and patterns of aldosterone secretion |
| Results | Continuous monitoring revealed hidden nocturnal hormone bursts. |
Literature Review: Related Studies
To place this study in context, we searched the Consensus database of over 200 million research papers using the following queries:
- hormone disorder high blood pressure
- nocturnal hormone bursts hypertension
- continuous monitoring blood pressure effects
The following table summarizes key topics and findings from the related literature:
| Topic | Key Findings |
|---|---|
| How do hormone disorders contribute to hypertension? | - Aldosterone excess increases blood pressure primarily via enhanced sodium reabsorption in the kidney and altered circadian rhythms 4 10. - Other endocrine disorders (e.g., thyroid disease, Cushing's syndrome) can cause or worsen hypertension, often through complex interactions with vascular and metabolic systems 2 3. |
| What is the significance of circadian and nocturnal hormone rhythms? | - Blood pressure and hormone levels exhibit circadian patterns; disruption or abnormal nocturnal surges in aldosterone and related hormones are linked to worse blood pressure profiles and higher cardiovascular risk 8 10. - Nocturnal hypertension, influenced by hormone fluctuations, is associated with increased morbidity and may go undetected without 24-hour monitoring 6 9. |
| Does continuous or ambulatory monitoring improve diagnosis/outcomes? | - Continuous or ambulatory monitoring (of blood pressure or hormones) provides a more accurate and comprehensive assessment than single-point measurements, potentially reducing missed diagnoses and improving treatment 10 11 12 13 14 15. - Wearable and noninvasive devices are increasingly validated for both hormone and blood pressure monitoring, enhancing clinical utility 14 15. |
| How does treatment of underlying hormone disorders affect hypertension? | - Treating the source of hormone excess (e.g., adrenal gland removal in primary aldosteronism or surgery for Cushing's syndrome) often leads to improved blood pressure control, though residual hypertension can persist in some patients 3 10. - Hormone therapy and other interventions may have varied impacts on blood pressure depending on formulation and individual characteristics 5. |
How do hormone disorders contribute to hypertension?
The literature consistently describes a strong link between endocrine disorders and the development or exacerbation of hypertension. Aldosterone, in particular, has a central role in blood pressure regulation by controlling renal sodium reabsorption, with excess production (as in primary aldosteronism) leading to persistent high blood pressure. Other hormone disorders, such as thyroid dysfunction and Cushing's syndrome, can also raise blood pressure through different but sometimes overlapping mechanisms 2 3 4 10.
- Aldosterone's effect on the epithelial sodium channel in the kidneys is a primary pathway for blood pressure elevation 4.
- High plasma aldosterone concentrations have been correlated with worse 24-hour blood pressure profiles and increased nocturnal hypertension risk 10.
- Secondary hypertension due to hormonal disorders is often underdiagnosed, especially in mild or subclinical cases 2 3.
- Early identification and management of endocrine causes can improve patient outcomes, underscoring the importance of targeted diagnostic approaches 3 4.
What is the significance of circadian and nocturnal hormone rhythms?
Circadian and nocturnal rhythms play a critical role in both hormone secretion and blood pressure regulation. Studies have shown that the usual night-time decline in blood pressure ("dipping") can be blunted or reversed in the context of hormonal abnormalities, particularly in primary aldosteronism, leading to nocturnal hypertension and higher cardiovascular risk 6 8 9 10.
- Abnormal nocturnal surges in hormones like aldosterone are associated with diminished night-time blood pressure dipping and increased cardiovascular events 8 10.
- Nocturnal hypertension, which may go unrecognized by daytime clinic measurements, is linked to target-organ damage and poor outcomes 6 9.
- The new study's identification of hidden nighttime hormone bursts is consistent with these findings, highlighting the importance of time-resolved measurement 10.
- Environmental and behavioral factors interact with endogenous circadian rhythms to influence both blood pressure and hormone patterns 8.
Does continuous or ambulatory monitoring improve diagnosis/outcomes?
The utility of continuous or ambulatory monitoring—whether for blood pressure or hormone levels—has been increasingly recognized in both research and clinical practice. Such approaches allow for detection of transient events and better assessment of circadian variability, thereby improving diagnostic accuracy and potentially leading to better hypertension management 10 11 12 13 14 15.
- Continuous hormone monitoring, as used in the new study, can detect dynamic fluctuations missed by single-point testing 10 14.
- Ambulatory blood pressure monitoring is already established as superior to office-based measurement for diagnosing hypertension and assessing cardiovascular risk 12 13.
- Advances in wearable technology have enabled more frequent, noninvasive, and user-friendly data collection, facilitating integration into routine care 14 15.
- The evidence suggests that capturing the temporal dynamics of blood pressure and hormones is clinically valuable for diagnosis and treatment adjustment 10 14.
How does treatment of underlying hormone disorders affect hypertension?
Effective intervention targeting the underlying hormonal cause of hypertension—such as surgical removal of an adrenal adenoma in primary aldosteronism or pituitary surgery in Cushing's syndrome—typically results in significant blood pressure improvement, though not all patients achieve full normalization 3 10.
- In primary aldosteronism, surgical removal of the affected adrenal gland abolishes abnormal hormone surges and can cure or ameliorate hypertension 10.
- Persistent hypertension after treatment may be due to irreversible vascular changes or coexisting primary hypertension 3.
- Hormone therapies, particularly those involving estrogen and progestogen, may increase or decrease blood pressure depending on the formulation and patient characteristics 5.
- Accurate identification of the hormone disorder is crucial for selecting the most effective therapeutic strategy 3 5 10.
Future Research Questions
While the new study offers significant insights into the diagnosis of hormone-driven hypertension, several important questions remain. Future research is needed to clarify the clinical implications of continuous hormone monitoring, optimize diagnostic criteria, and determine the best strategies for integrating wearable technology into routine care.
| Research Question | Relevance |
|---|---|
| How should continuous hormone profiles be interpreted for diagnosing primary aldosteronism? | Defining diagnostic thresholds and criteria for dynamic hormone data is essential for clinical adoption; current guidelines are based on static measurements and may need revision 10 14. |
| What are the clinical outcomes of using wearable hormone monitors in hypertension management? | Assessing whether wearable continuous monitoring translates into improved patient outcomes, such as reduced cardiovascular events or better blood pressure control, is crucial for evidence-based implementation 14 15. |
| Can continuous monitoring identify subclinical or early-stage primary aldosteronism? | Early detection of subtle hormone abnormalities could allow for intervention before irreversible organ damage occurs, addressing a current gap in diagnosis 2 10. |
| How do nocturnal hormone patterns relate to long-term cardiovascular risk in hypertensive patients? | Understanding the prognostic value of nocturnal hormone surges may inform risk stratification and personalized therapy, especially since nocturnal hypertension is linked to worse outcomes 6 8 10. |
| What are the cost-effectiveness and practicality of implementing continuous hormone monitoring in clinical practice? | Evaluating economic and logistical aspects will determine the feasibility of widespread adoption of wearable hormone monitoring, complementing evidence of clinical utility 14 15. |